Joel Beatty

Stock Analyst at Baird

(4.08)
# 389
Out of 4,839 analysts
200
Total ratings
41.25%
Success rate
15.37%
Average return

Stocks Rated by Joel Beatty

ACADIA Pharmaceuticals
May 19, 2025
Maintains: Outperform
Price Target: $28$31
Current: $21.55
Upside: +43.85%
Neurogene
May 16, 2025
Downgrades: Neutral
Price Target: $38$24
Current: $18.04
Upside: +33.04%
e.l.f. Beauty
May 14, 2025
Maintains: Outperform
Price Target: $85$100
Current: $82.78
Upside: +20.80%
Editas Medicine
May 13, 2025
Maintains: Outperform
Price Target: $8$4
Current: $1.62
Upside: +146.91%
Dianthus Therapeutics
May 13, 2025
Maintains: Outperform
Price Target: $58$50
Current: $18.36
Upside: +172.33%
argenx SE
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $582.13
Upside: +16.81%
Denali Therapeutics
May 8, 2025
Maintains: Outperform
Price Target: $30$29
Current: $13.66
Upside: +112.30%
PTC Therapeutics
May 7, 2025
Maintains: Outperform
Price Target: $70$66
Current: $45.47
Upside: +45.15%
Jazz Pharmaceuticals
May 7, 2025
Maintains: Outperform
Price Target: $167$155
Current: $107.82
Upside: +43.76%
Cogent Biosciences
May 7, 2025
Maintains: Neutral
Price Target: $8$7
Current: $4.95
Upside: +41.41%
Maintains: Outperform
Price Target: $160$162
Current: $104.35
Upside: +55.25%
Maintains: Outperform
Price Target: $38$41
Current: $30.05
Upside: +36.44%
Maintains: Outperform
Price Target: $13$10
Current: $1.94
Upside: +416.80%
Maintains: Outperform
Price Target: $27$16
Current: $7.07
Upside: +126.31%
Maintains: Outperform
Price Target: $32$16
Current: $3.92
Upside: +308.16%
Maintains: Outperform
Price Target: $117$73
Current: $38.34
Upside: +90.40%
Maintains: Outperform
Price Target: $28$32
Current: $24.11
Upside: +32.73%
Initiates: Outperform
Price Target: $75
Current: $30.22
Upside: +148.18%
Upgrades: Outperform
Price Target: $3$11
Current: $5.35
Upside: +105.61%
Maintains: Outperform
Price Target: $6$7
Current: $1.97
Upside: +255.33%
Maintains: Neutral
Price Target: $72$65
Current: $58.01
Upside: +12.05%
Maintains: Neutral
Price Target: $13$9
Current: $6.61
Upside: +36.16%
Maintains: Outperform
Price Target: $112$127
Current: $100.36
Upside: +26.54%
Maintains: Outperform
Price Target: $68$72
Current: $35.52
Upside: +102.70%
Maintains: Outperform
Price Target: $45$20
Current: $0.41
Upside: +4,730.92%
Downgrades: Neutral
Price Target: $4.5
Current: $1.48
Upside: +204.05%
Maintains: Outperform
Price Target: $24$25
Current: $10.03
Upside: +149.25%
Maintains: Outperform
Price Target: $11$9
Current: $0.37
Upside: +2,337.70%
Maintains: Outperform
Price Target: $32$28
Current: $10.81
Upside: +159.02%
Initiates: Outperform
Price Target: $16
Current: $7.50
Upside: +113.33%
Maintains: Outperform
Price Target: $4$1.25
Current: $1.69
Upside: -26.04%
Initiates: Outperform
Price Target: $44
Current: $1.34
Upside: +3,183.58%
Maintains: Outperform
Price Target: $60$58
Current: $15.39
Upside: +276.87%
Maintains: Outperform
Price Target: $18$24
Current: $18.68
Upside: +28.48%
Downgrades: Underperform
Price Target: $18
Current: $12.80
Upside: +40.63%
Maintains: Outperform
Price Target: $9$6
Current: $2.88
Upside: +108.33%
Maintains: Outperform
Price Target: $46$31
Current: $1.20
Upside: +2,483.33%
Upgrades: Neutral
Price Target: $36$28
Current: $4.61
Upside: +507.38%
Downgrades: Neutral
Price Target: $170$175
Current: $289.00
Upside: -39.45%
Downgrades: Neutral
Price Target: $14
Current: $4.24
Upside: +230.19%
Downgrades: Neutral
Price Target: $108
Current: $38.79
Upside: +178.42%
Maintains: Buy
Price Target: $80$78
Current: $33.26
Upside: +134.52%
Maintains: Buy
Price Target: $140$100
Current: $8.77
Upside: +1,040.25%
Maintains: Buy
Price Target: $480$120
Current: $10.99
Upside: +991.90%
Maintains: Buy
Price Target: $480$450
Current: $3.23
Upside: +13,831.89%
Upgrades: Buy
Price Target: n/a
Current: $0.80
Upside: -
Maintains: Buy
Price Target: $19$15
Current: $7.29
Upside: +105.76%
Maintains: Neutral
Price Target: $240$120
Current: $0.67
Upside: +17,864.07%
Maintains: Buy
Price Target: $15$19
Current: $6.24
Upside: +204.49%